<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30248155</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Electronic">1932-6203</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>13</Volume>                    <Issue>9</Issue>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>PloS one</Title>                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>            </Journal>            <ArticleTitle>Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.</ArticleTitle>            <Pagination>                <MedlinePgn>e0204372</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0204372</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To date, studies on inflammatory breast cancer (IBC) lack comprehensive epidemiological data. We analyzed detailed prospectively collected clinical and epidemiological data from the IBC Registry at The University of Texas MD Anderson Cancer Center.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Patients with IBC (n = 248) were consecutively diagnosed and prospectively enrolled between November 2006 and April 2013. All patients were newly diagnosed and at least 18 years old. Secondary IBC was excluded. Overall 160 variables were collected and evaluated including sociodemographics, anthropometrics, tobacco and alcohol consumption, reproductive variables, and family history data.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean age at diagnosis was 51.6 (±11.5 SD) years, and the majority of patients were White (77.8%). A mean BMI ≥ 25 kg/m2, irrespective of menopausal status, was observed in 80.2% of all patients, with 82.6% of African Americans being obese. Approximately 42.2% of patients were ever smokers, and 91% reported ever being pregnant. A history of breastfeeding was reported in 54% of patients, with significant differences between ethnic groups in favor of White women (P&lt;0.0001). Other reproductive factors such as use of birth control pills &amp; hormone replacement therapy were also more frequently associated with White women compare to other ethnic groups (P &lt; 0.05). In the multivariate Cox proportional hazard analysis, African American or Hispanic ethnicity, not having breastfed, higher clinical stage, and TNBC subtype were associated with shorter survival.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our data suggest that IBC is associated with distinct epidemiological profiles. This information could assist in targeting patients with specific preventive strategies based on their modifiable behavioral patterns.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Fouad</LastName>                    <ForeName>Tamer M</ForeName>                    <Initials>TM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ueno</LastName>                    <ForeName>Naoto T</ForeName>                    <Initials>NT</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yu</LastName>                    <ForeName>Robert K</ForeName>                    <Initials>RK</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ensor</LastName>                    <ForeName>Joe E</ForeName>                    <Initials>JE</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Alvarez</LastName>                    <ForeName>Ricardo H</ForeName>                    <Initials>RH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Krishnamurthy</LastName>                    <ForeName>Savitri</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lucci</LastName>                    <ForeName>Anthony</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Reuben</LastName>                    <ForeName>James M</ForeName>                    <Initials>JM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yang</LastName>                    <ForeName>Wei</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Willey</LastName>                    <ForeName>Jie S</ForeName>                    <Initials>JS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Valero</LastName>                    <ForeName>Vicente</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bondy</LastName>                    <ForeName>Melissa L</ForeName>                    <Initials>ML</Initials>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cristofinalli</LastName>                    <ForeName>Massimo</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shete</LastName>                    <ForeName>Sanjay</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Woodward</LastName>                    <ForeName>Wendy A</ForeName>                    <Initials>WA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>El-Zein</LastName>                    <ForeName>Randa</ForeName>                    <Initials>R</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0750-4143</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>24</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>PLoS One</MedlineTA>            <NlmUniqueID>101285081</NlmUniqueID>            <ISSNLinking>1932-6203</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>AJR Am J Roentgenol. 2011 Oct;197(4):W769-76</RefSource>                <PMID Version="1">21940550</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Jul;152(2):407-16</RefSource>                <PMID Version="1">26017070</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer. 2017 Jul 1;8(10):1726-1732</RefSource>                <PMID Version="1">28819368</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2015 Nov;16(15):e568-e576</RefSource>                <PMID Version="1">26545845</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2001 Nov-Dec;7(6):398-404</RefSource>                <PMID Version="1">11843851</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Epidemiol. 2000 Sep 15;152(6):514-27</RefSource>                <PMID Version="1">10997541</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2011 Mar;22(3):515-23</RefSource>                <PMID Version="1">20603440</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2001 Oct 27;358(9291):1389-99</RefSource>                <PMID Version="1">11705483</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Surg Oncol. 2018 Aug;44(8):1128-1134</RefSource>                <PMID Version="1">29706301</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Environ. 2017 Feb 1;39:10</RefSource>                <PMID Version="1">28163803</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 1985 Feb;74(2):291-7</RefSource>                <PMID Version="1">3856043</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Oncol. 2008 Feb;35(1):11-6</RefSource>                <PMID Version="1">18308141</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2005 Jul 6;97(13):966-75</RefSource>                <PMID Version="1">15998949</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1980 Dec 15;46(12):2741-6</RefSource>                <PMID Version="1">7448713</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Causes Control. 2016 Mar;27(3):359-66</RefSource>                <PMID Version="1">26797453</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1998 Jun 15;82(12):2366-72</RefSource>                <PMID Version="1">9635529</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Causes Control. 2004 Apr;15(3):321-8</RefSource>                <PMID Version="1">15090727</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):567-71</RefSource>                <PMID Version="1">7549816</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Dis. 2005-2006;22:9-23</RefSource>                <PMID Version="1">16735783</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2013 Nov 1;31(31):3997-4013</RefSource>                <PMID Version="1">24101045</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2010;12(3):205</RefSource>                <PMID Version="1">20584344</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1998 Dec;16(12):3731-5</RefSource>                <PMID Version="1">9850015</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Jun 1;28(16):2784-95</RefSource>                <PMID Version="1">20404251</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2006 Dec;7(5):386-95</RefSource>                <PMID Version="1">17239263</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 1997 Sep 4;72(5):720-7</RefSource>                <PMID Version="1">9311584</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <CoiStatement>The authors declare no potential conflicts of interest.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30248155</ArticleId>            <ArticleId IdType="doi">10.1371/journal.pone.0204372</ArticleId>            <ArticleId IdType="pii">PONE-D-18-15490</ArticleId>            <ArticleId IdType="pmc">PMC6152950</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>